869 results on '"de Ferranti, Sarah"'
Search Results
52. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction
53. Special Considerations for Healthy Lifestyle Promotion Across the Life Span in Clinical Settings: A Science Advisory From the American Heart Association
54. Elevation of IL-17 Cytokines Distinguishes Kawasaki Disease From Other Pediatric Inflammatory Disorders.
55. Cardiac Biomarkers Aid in Differentiation of Kawasaki Disease from Multisystem Inflammatory Syndrome in Children Associated with COVID-19
56. Elevation of IL‐17 cytokines distinguishes Kawasaki disease from other pediatric inflammatory disorders
57. Still “on the Fence” About Universal Childhood Lipid Screening
58. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel
59. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children
60. Safety and Efficacy of Warfarin Therapy in Kawasaki Disease
61. Stakeholders’ Perspectives on Stakeholder-engaged Research (SER) : Strategies to Operationalize Patient-centered Outcomes Research Principles for SER
62. Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry
63. Abstract 194: Age, Gender, Race/ethnicity, and Income-related Patterns in Ideal Cardiovascular Health
64. Abstract 12598: Stress Testing During Long-term Follow-up After Kawasaki Disease
65. Statin-Associated Myopathy in a Pediatric Preventive Cardiology Practice
66. Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians
67. Kawasaki disease and immunisation: A systematic review
68. Transitioning from pediatric to adult health care with familial hypercholesterolemia: Listening to young adult and parent voices
69. The American Heart Association 2030 Impact Goal: A Presidential Advisory From the American Heart Association
70. 52 - Evaluating murmurs, chest pain, and syncope
71. 44 - Preventive cardiology
72. Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis
73. Nutrition in Children and Adolescents
74. Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia
75. The association of objectively measured sedentary time with asthma in US youth: A glimpse into the connection between obesity and asthma
76. Adherence to lipid-lowering therapy and reaching treatment goals in youth seen in a preventive cardiology clinic
77. Using Adult Ambulatory Blood Pressure Thresholds in Youth: Impact of Nocturnal Hypertension
78. Lack of Age-Appropriate Reference Intervals Causing Potentially Missed Alerts in Clinical Reports of Dyslipidemia
79. Adolescent Perceptions of Cholesterol Screening Results: “Young Invincibles” or Developing Adults?
80. Drug Therapy for Hypercholesterolemia and Dyslipidemia
81. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
82. Wearable Biosensors in Pediatric Cardiovascular Disease: Promises and Pitfalls Toward Generating Actionable Insights
83. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association
84. Familial hypercholesterolemia in children and adolescents: A clinical perspective
85. Treatment decision making for adolescents with familial hypercholesterolemia: Role of family history and past experiences
86. Clinical response to lifestyle counseling for dyslipidemia and elevated blood pressure in childhood cancer survivors
87. Cardiovascular Risk Assessment and Management for Pediatricians
88. Prevalence of High Blood Pressure Among Youth in India and Association With Future Cardiovascular Disease
89. Atherosclerotic Cardiovascular Risk as an Emerging Priority in Pediatrics
90. Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of p ostacute sequelae of SARS‐CoV ‐2 infection ( PASC ) in children and adolescents
91. Association of Acute Anti-inflammatory Treatment With Medium-term Outcomes for Coronary Artery Aneurysms in Kawasaki Disease
92. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
93. Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action
94. Drug Therapy for Hypercholesterolemia and Dyslipidemia
95. Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women
96. Abstract 18575: Comparative Effectiveness of Adolescent Cholesterol Screening and Treatment Strategies
97. USPSTF is unable to recommend for or against lipid screening to identify multifactorial dyslipidaemia in childhood: no recommendation is not without consequences
98. Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults
99. Age, Sex, Race/Ethnicity, and Income Patterns in Ideal Cardiovascular Health Among Adolescents and Adults in the U.S.
100. Vascular Health in Kawasaki Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.